In:
CNS Oncology, Future Medicine Ltd, Vol. 1, No. 1 ( 2012-09), p. 25-27
Abstract:
Martin J van den Bent is trained as a neurologist. Since 1992, he has worked at the Neuro-Oncology Unit of Erasmus MC – Daniel den Hoed Cancer Center in Rotterdam, The Netherlands. In 2002 he became the head of the Neuro-Oncology Unit, which is focused on the treatment of primary brain tumors and on neurological complications of cancer and its treatment. He is currently Professor of Neuro-Oncology at Erasmus University, Rotterdam. He has been the principle investigator of a large number of international multicenter trials on both high- and low-grade glial tumors, most of which were conducted through the European Organisation for Research and Treatment of Cancer Brain Tumor Group. Many of these trials included translational research projects, focusing on the identification of prognostic and predictive molecular parameters of outcomes of treatment. He was Secretary of the European Organisation for Research and Treatment of Cancer Brain Tumor Group from 1996 to 2002 and from 2002 to 2009 he was Chair of this internationally recognized group. He has served as Chairman of the CNS section of the 14th European Cancer Conference and of the Dutch Neuro-Oncology Working Group. He has published widely, not only on the treatment of primary brain tumors, but also on neurological complications of systemic cancers. He has chaired and lectured at numerous national and international educational symposia and scientific meetings on neuro-oncology and serves on the editorial board of several oncology journals, including CNS Oncology. He has written chapters in many textbooks on neuro-oncology and is active in the Response Assessment in Neuro-Oncology Group revising the end points and response criteria of trials in neuro-oncology.
Type of Medium:
Online Resource
ISSN:
2045-0907
,
2045-0915
Language:
English
Publisher:
Future Medicine Ltd
Publication Date:
2012
detail.hit.zdb_id:
2692808-5
Permalink
